Showing results (81-90 of 97) with videos related to
Sort By:
Pageof 10
The Lancet. Psychiatry|July 14, 2018
Cognitive behavioural therapy in clozapine-resistant schizophrenia (FOCUS): an assessor-blinded, randomised controlled trialAnthony P Morrison, Melissa Pyle, Andrew Gumley, et al.Brain, Behavior, and Immunity|November 8, 2020
Deconstructing depression and negative symptoms of schizophrenia; differential and longitudinal immune correlates, and response to minocycline treatmentCarl R Krynicki, Paola Dazzan, Carmine M Pariante, et al.Health Technology Assessment (Winchester, England)|April 21, 2016
Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trialThomas R E Barnes, Verity C Leeson, Carol Paton, et al.BMJ (Clinical Research Ed.)|March 1, 2012
Group art therapy as an adjunctive treatment for people with schizophrenia: multicentre pragmatic randomised trialMike J Crawford, Helen Killaspy, Thomas R E Barnes, et al.Therapeutic Advances in Psychopharmacology|May 5, 2022
The clinical effectiveness and cost effectiveness of clozapine for inpatients with severe borderline personality disorder (CALMED study): a randomised placebo-controlled trialMike J Crawford, Verity C Leeson, Rachel Evans, et al.Trials|June 9, 2019
Intravenous immunoglobulin and rituximab versus placebo treatment of antibody-associated psychosis: study protocol of a randomised phase IIa double-blinded placebo-controlled trial (SINAPPS2)Belinda Lennox, Ksenija Yeeles, Peter B Jones, et al.Brain, Behavior, and Immunity|July 9, 2023
Inflammatory subgroups of schizophrenia and their association with brain structure: A semi-supervised machine learning examination of heterogeneityParis Alexandros Lalousis, Lianne Schmaal, Stephen J Wood, et al.Journal of Neuroscience Research|May 4, 2011
Transcription and pathway analysis of the superior temporal cortex and anterior prefrontal cortex in schizophreniaMichael R Barnes, Julie Huxley-Jones, Peter R Maycox, et al.Translational Psychiatry|September 18, 2023
Network analysis of inflammation and symptoms in recent onset schizophrenia and the influence of minocycline during a clinical trialSarah E Herniman, Stephen J Wood, Golam Khandaker, et al.Schizophrenia Research|August 14, 2024
Efficacy and tolerability of antipsychotic polypharmacy for schizophrenia spectrum disorders. A systematic review and meta-analysis of individual patient dataMarc W H Lochmann van Bennekom, Joanna IntHout, Harm J Gijsman, et al.Pageof 10